Summary & Overview
CPT 0738T: MRI-Based Treatment Planning for Prostate Nanoparticle Thermal Ablation
CPT code 0738T designates a treatment-planning service that uses previously obtained MRI data to plan thermal ablation of malignant prostate tissue via a magnetic field and injected nanoparticles. The code captures an image-based planning step integral to a novel, image-guided focal therapy approach for prostate cancer. Nationally, adoption of advanced focal-therapy techniques and accompanying planning services is of interest to payers and providers because planning can influence procedure success, resource use, and coverage policy.
Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for image-guided nanoparticle-mediated thermal ablation, typical sites of service, and the role of MRI-derived planning. The publication outlines common billing considerations, reported modifiers associated with this service, and available national policy context. It also highlights benchmarks and coverage patterns where available and notes where input data is not provided.
This summary provides clinicians, billing professionals, and policy teams with a concise reference to the clinical purpose of CPT code 0738T, the payer landscape under review, and the types of operational and policy questions that typically arise when integrating advanced focal prostate ablation services into practice.
Billing Code Overview
CPT code 0738T describes use of data from a previously performed magnetic resonance imaging (MRI) study to complete treatment planning for malignant prostate tissue ablation that employs a magnetic field to heat injected nanoparticles. This procedure is a treatment-planning service supporting a focused thermal ablation technique for prostate cancer.
-
Service type: Treatment planning using prior imaging data for ablation therapy
-
Typical site of service: Outpatient imaging or procedural planning setting associated with oncology or interventional radiology services
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old man with biopsy-proven localized, recurrent, or focal high-grade prostate adenocarcinoma is evaluated for focal thermal ablation using magnetic nanoparticle hyperthermia. The patient previously underwent a diagnostic multiparametric MRI of the prostate with tumor localization and planning sequences. At a multidisciplinary planning visit, the interventional urologist or interventional radiologist reviews the prior MRI to delineate tumor margins, plan needle trajectories, and determine nanoparticle injection volumes and heating parameters. The procedure typically occurs in an outpatient ambulatory surgical center or hospital outpatient department with monitored anesthesia care or general anesthesia. Pre-procedure workflow includes review of prior MRI images, informed consent, medication reconciliation, and peri-procedural antibiotic prophylaxis as indicated. Imaging guidance during the ablation may use transrectal ultrasound with fusion to the prior MRI. Post-procedure workflow includes immediate recovery, post-ablation imaging as indicated, pain control, and scheduling follow-up PSA testing and surveillance MRI to assess treatment effect.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work, time, or complexity of the planning is substantially greater than typical for 0738T. |
52 | Reduced services | Use when limited elements of the planning service were performed and the full service was not completed. |
53 | Discontinued procedure | Use if planning was begun but the encounter was terminated before completion for patient-related or safety reasons. |
62 | Two surgeons | Use when two surgeons work together as primary surgeons during planning or intra-procedural decision-making. |
80 | Assistant surgeon | Use when an assistant surgeon provides documented assistance during procedural planning steps or intraoperative management. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist service | Use when an advanced practice clinician performs or assists with components of the planning under appropriate state law and payer rules. |
CQ | Service by a registered nurse anesthetist | Use when a CRNA provides anesthesia services for the ablation procedure tied to planning and treatment. |
QK | Medical direction of two, three, or four concurrent anesthesia procedures | Use if the physician directs multiple concurrent anesthesia procedures during the ablation session. |
QX | CRNA service with medical direction by a physician (when allowed) | Use when both CRNA and physician direction qualifications apply per payer rules. |
QY | Medical direction of one CRNA by an anesthesiologist | Use when an anesthesiologist medically directs a CRNA for this procedure. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 208800000X | Urology | Urologists commonly refer, plan, and perform prostate focal ablation procedures. |
| 207P00000X | Interventional Radiology | Interventional radiologists perform image-guided nanoparticle injection and ablation planning. |
| 363L00000X | Radiation Oncology | Radiation oncologists may participate in multidisciplinary planning for focal prostate treatments. |
| 2086S0202X | Surgical Oncology | Surgical oncologists with genitourinary focus may be involved in selection and planning. |
| 363A00000X | Anesthesiology | Anesthesiologists provide sedation or general anesthesia for the ablation procedure. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
C61 | Malignant neoplasm of prostate | Primary diagnosis indicating prostate cancer for which focal nanoparticle hyperthermia planning is performed. |
N40.1 | Benign prostatic hyperplasia with lower urinary tract symptoms | Common comorbidity that may influence procedural approach, anesthesia, and urinary symptom management. |
D07.5 | Carcinoma in situ of prostate | Pre-invasive lesion that may be part of consideration in targeted focal treatments for gland-sparing therapy. |
N41.0 | Acute prostatitis | Active infection that may contraindicate immediate ablation; relevant to pre-procedure evaluation. |
Z12.5 | Encounter for screening for malignant neoplasm of prostate | Screening and surveillance context when MRI findings prompt targeted planning for focal therapy. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
55866 | Laparoscopic radical prostatectomy, retropubic, with or without robotic assistance | Alternative definitive surgical treatment; may be considered before or after focal therapy in treatment planning discussions. |
52000 | Cystourethroscopy, diagnostic | Used for pre-procedural evaluation of the lower urinary tract when indicated prior to focal prostate procedures. |
76942 | Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection), imaging supervision and interpretation | Used during nanoparticle injection and intra-procedural needle placement with transrectal ultrasound fusion to MRI. |
72195 | Magnetic resonance (eg, prostate) pelvis without contrast, followed by contrast and further sequences (dynamic) | A prior multiparametric MRI used for planning; imaging referenced in 0738T. |
77301 | Radiation therapy planning simulation, complex | Related multidisciplinary planning code used when radiation therapy planning is concurrently required in treatment strategy. |